The Monitoring of Infliximab Levels at Early Stages Can Predict the Development of Anti-Infliximab Antibodies in a Cohort of Rheumatoid Arthritis Patients Treated with Infliximab

被引:0
|
作者
Plasencia-Rodriguez, Chamaida [1 ]
Pascual-Salcedo, Dora [2 ]
Gema Bonilla, Maria [2 ]
Villalba, Alejandro [1 ]
Peiteado, Diana [1 ]
Nuno, Laura [3 ]
Aguado, Pilar [4 ]
Jurado, Teresa [4 ]
Martin-Mola, Emilio [2 ]
Balsa, Alejandro [3 ]
机构
[1] Hosp La Paz IdiPaz, Madrid, Spain
[2] La Paz Univ Hosp, Madrid, Spain
[3] Hosp La Paz IdiPaz, Madrid, Spain
[4] La Paz Univ Hosp Idipaz, Madrid, Spain
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
2513
引用
收藏
页码:S1098 / S1098
页数:1
相关论文
共 50 条
  • [1] THE EARLY INFLIXIMAB LEVELS MONITORING CAN PREDICT THE DEVELOPEMENT OF ANTI-DRUG ANTIBODIES IN A COHORT OF RHEUMATOID ARTHRITIS PATIENTS TREATED WITH INFLIXIMAB
    Chamaida, P. -R.
    Pascual-Salcedo, D.
    Bonilla, M.
    Villalba, A.
    Lopez-Casla, M.
    Peiteado, D.
    Garcia-Carazo, S.
    Ramiro, S.
    Franco, K.
    Cajigas, D.
    Martin-Mola, E.
    Balsa, A.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2014, 73 : 157 - 157
  • [2] Low infliximab serum trough levels and anti-infliximab antibodies are prevalent in rheumatoid arthritis patients treated with infliximab in daily clinical practice: results of an observational cohort study
    van der Maas, Aatke
    van den Bemt, Bart J. F.
    Wolbink, Gertjan
    van den Hoogen, Frank H. J.
    van Riel, Piet L. C. M.
    den Broeder, Alfons A.
    [J]. BMC MUSCULOSKELETAL DISORDERS, 2012, 13
  • [3] Low infliximab serum trough levels and anti-infliximab antibodies are prevalent in rheumatoid arthritis patients treated with infliximab in daily clinical practice: results of an observational cohort study
    Aatke van der Maas
    Bart JF van den Bemt
    Gertjan Wolbink
    Frank HJ van den Hoogen
    Piet LCM van Riel
    Alfons A den Broeder
    [J]. BMC Musculoskeletal Disorders, 13
  • [4] Anti-infliximab antibodies in RA patients treated with infliximab.
    Wolbink, GJ
    Lems, WF
    Nurmohamed, MT
    Vis, M
    Voskuyl, AE
    Stapel, S
    de Groot, E
    Tak, PP
    Dijkmans, BA
    Aarden, L
    [J]. ARTHRITIS AND RHEUMATISM, 2004, 50 (09): : S187 - S187
  • [5] ESTABLISHING CUT-OFF OF INFLIXIMAB LEVELS AND ANTI-INFLIXIMAB ANTIBODIES BY COMMERCIAL ELISA IN PATIENTS WITH RHEUMATOID ARTHRITIS
    Hernandez, Diana
    Valor, Lara
    de la Torre, Inmaculada
    Martinez, Lina
    Carlos Nieto, Juan
    del Rio, Tamara
    Naredo, Esperanza
    Gonzalez, Carlos
    Lopez-Longo, Javier
    Montoro, Maria
    Monteagudo, Indalecio
    Carreno, Luis
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2014, 73 : A11 - A11
  • [6] Serum trough infliximab and anti-infliximab antibodies in a cohort of gastroenterology and rheumatology patients' infliximab therapeutic drug monitoring
    Barlow, Nicola L.
    Mohammed, Pervaz
    Berg, Jonathan D.
    [J]. ANNALS OF CLINICAL BIOCHEMISTRY, 2016, 53 (04) : 477 - 484
  • [7] Detection of anti-infliximab antibodies is of limited value to predict acquired drug resistance to infliximab in rheumatoid arthritis
    Finckh, Axel
    Dudler, Jean
    Wennelinger, Felix
    Ciurca, Adrian
    Gabay, Cem
    Bas, Sylvette
    [J]. ARTHRITIS AND RHEUMATISM, 2008, 58 (09): : S777 - S777
  • [8] Clinical Response in Rheumatoid Arthritis Patients with Anti-Infliximab Antibodies
    Opris, Daniela
    Mazilu, Diana
    Ionescu, Ruxandra
    [J]. CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2014, 32 (04) : S40 - S41
  • [9] Commentary: detection of infliximab levels and anti-infliximab antibodies
    Seow, C. H.
    Panaccione, R.
    [J]. ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2013, 37 (01) : 153 - 154
  • [10] Influence of anti-infliximab antibodies and residual infliximab concentrations on the occurrence of acquired drug resistance to infliximab in rheumatoid arthritis patients
    Finckh, Axel
    Dudler, Jean
    Wermelinger, Felix
    Ciurea, Adrian
    Kyburz, Diego
    Gabay, Cem
    Bas, Sylvette
    [J]. JOINT BONE SPINE, 2010, 77 (04) : 313 - 318